US2015191540A1PendingUtilityA1
Preventive or therapeutic agent for sensitized t cell-mediated diseases comprising il-6 antagonist as an active ingredient
Assignee: CHUGAI PHARMACEUTICAL CO LTDPriority: Mar 21, 1997Filed: Mar 18, 2015Published: Jul 9, 2015
Est. expiryMar 21, 2017(expired)· nominal 20-yr term from priority
Inventors:Masahiko Mihara
C07K 16/248A61K 2039/505A61P 37/06C07K 2317/76C07K 16/2866A61P 37/00A61K 39/395
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A preventive or therapeutic agent for sensitized T cell-mediated diseases comprising an interleukin-6 (IL-6) antagonist, for example an antibody directed against IL-6 receptor, an antibody directed against IL-6, an antibody directed against gp130, and the like.
Claims
exact text as granted — not AI-modified1 . A preventive or therapeutic agent for sensitized T cell-mediated diseases comprising an interleukin-6 (IL-6) antagonist as an active ingredient.
Join the waitlist — get patent alerts
Track US2015191540A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.